WuXi Healthcare Ventures Makes Two US Biopharma Investments

WuXi Healthcare Ventures (WXHV) of Shanghai announced two new investments in US biopharma companies. WXHV, which closed its $290 million second fund last month, participated in the latest rounds for Twist Bioscience of San Francisco and Syros Pharma of Cambridge, MA. Twist has developed an automated silicon platform for making synthetic genes, and Syros is advancing the use of proprietary gene control elements to fight cancer. The size of WXHV's investments was not disclosed. More details.... Share this with colleagues: // //